DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Rossari Biotech Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·10 Sept 2026, 2:32 pm

Rossari Biotech

Rossari Biotech has announced its upcoming Analyst and Institutional Investor Meet. This event provides a platform for the company's management to engage with financial experts and institutional investors to discuss its business strategy and performance.

For investors, these interactions are crucial as they offer a direct insight into the company's future outlook and operational plans. It allows the market to gauge management's confidence and clarity on growth initiatives.

Investors should watch for updates on the company's guidance, expansion plans, and any commentary on the competitive landscape. This information will help in assessing the stock's potential and aligning investment decisions accordingly.